- Home
- INSM vs BNT Comparison
INSM vs BNT Comparison
Compare INSM & BNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INSM
- BNT
- Stock Information
- Founded
- INSM 1988
- BNT 2020
- Country
- INSM United States
- BNT Bermuda
- Employees
- INSM N/A
- BNT N/A
- Industry
- INSM Biotechnology: Pharmaceutical Preparations
- BNT
- Sector
- INSM Health Care
- BNT
- Exchange
- INSM Nasdaq
- BNT Nasdaq
- Market Cap
- INSM 12.6B
- BNT 14.4B
- IPO Year
- INSM 2000
- BNT N/A
- Fundamental
- Price
- INSM $69.73
- BNT $57.75
- Analyst Decision
- INSM Strong Buy
- BNT
- Analyst Count
- INSM 17
- BNT 0
- Target Price
- INSM $95.93
- BNT N/A
- AVG Volume (30 Days)
- INSM 2.3M
- BNT 12.0K
- Earning Date
- INSM 05-08-2025
- BNT 05-08-2025
- Dividend Yield
- INSM N/A
- BNT 0.59%
- EPS Growth
- INSM N/A
- BNT N/A
- EPS
- INSM N/A
- BNT 2.28
- Revenue
- INSM $381,030,000.00
- BNT $14,236,000,000.00
- Revenue This Year
- INSM $29.15
- BNT N/A
- Revenue Next Year
- INSM $115.02
- BNT N/A
- P/E Ratio
- INSM N/A
- BNT $25.39
- Revenue Growth
- INSM 20.77
- BNT 73.14
- 52 Week Low
- INSM $53.69
- BNT $40.12
- 52 Week High
- INSM $84.91
- BNT $62.72
- Technical
- Relative Strength Index (RSI)
- INSM 53.15
- BNT N/A
- Support Level
- INSM $65.56
- BNT N/A
- Resistance Level
- INSM $68.74
- BNT N/A
- Average True Range (ATR)
- INSM 2.41
- BNT 0.00
- MACD
- INSM 0.42
- BNT 0.00
- Stochastic Oscillator
- INSM 76.91
- BNT 0.00
About INSM Insmed Incorporated
Insmed Inc is a biopharmaceutical company transforming the lives of patients with serious and rare diseases. The company's first commercial product is ARIKAYCE (amikacin liposome inhalation suspension), approved in the US for the treatment of Mycobacterium Avium Complex (MAC) lung disease as part of a combination antibacterial drug regimen for adult patients with limited or no alternative treatment options. It is also developing Brensocatib, an oral reversible dipeptidyl peptidase 1 inhibitor for bronchiectasis and other neutrophil-mediated diseases, and Treprostinil Palmitil Inhalation Powder, an inhaled treprostinil prodrug for pulmonary hypertension linked to interstitial lung disease and pulmonary arterial hypertension.
About BNT Brookfield Wealth Solutions Ltd.
Brookfield Wealth Solutions Ltd, formerly Brookfield Reinsurance Ltd operates a capital solutions business providing insurance and reinsurance services to individuals and institutions. Through its subsidiary, the company offers a broad range of insurance products and services, including life insurance and annuities, and personal and commercial property and casualty insurance. It is organized into three reporting segments: Direct Insurance, Reinsurance, and Pension Risk Transfer (PRT).